Far more than a series of linear quality checkpoints along the way, RBQM spans the clinical trial continuum, scanning data as it accrues and assessing it holistically to detect issues or trends that require further evaluation. Amy Kissam-Sands at Parexel explores why companies must be committed to adopting this mindset for RBQM to be successfully applied across all clinical trials.